Table II.
Antimicrobial use in surgery department at QECH, Malawi
| Variables | All patients, N=29 n (%) |
Patients with HAI n (%)∗∗ |
Patients without HAI n (%)∗∗ |
|---|---|---|---|
| Number of AM prescribed | |||
| 1 | 13 (44.8) | 4 (30.8) | 9 (69.2) |
| 2 | 16 (55.2) | 7 (43.8) | 9 (56.2) |
| Purpose of AM use | |||
| Prophylactic | 3 (10.3) | 0 (0.0) | 3 (100) |
| Therapeutic | 14 (48.3) | 4 (28.6) | 10 (71.4) |
| Both | 12 (41.4) | 7 (58.3) | 5 (41.7) |
| AM prescribed∗ | |||
| Ceftriaxone | 15 (51.7) | 7 (46.7) | 8 (53.3) |
| Metronidazole | 13 (44.8) | 4 (30.8) | 9 (69.2) |
| Amoxicillin | 7 (24.1) | 3 (42.9) | 4 (57.1) |
| Doxycycline | 4 (13.8) | 2 (50.0) | 2 (50.0) |
| Ciprofloxacin | 4 (13.8) | 2 (50.0) | 2 (50.0) |
| Flucloxacillin | 2 (6.9) | 0 (0.0) | 2 (100) |
HAI: healthcare-associated infections, AM: antimicrobial agent.
∗
There are patients who received more than one antibiotic.
∗∗
Percentages of these columns are calculated by taking corresponding lines of the first columns as the total.